Corcept Therapeutics

$23.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+0.98%) As of 1:19 PM EST today

Why Robinhood?

You can buy or sell CORT and other stocks, options, and ETFs commission-free!

About CORT

Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA. The listed name for CORT is Corcept Therapeutics Incorporated Common Stock.

CEO
Joseph K. Belanoff
Employees
206
Headquarters
Menlo Park, California
Founded
1998
Market Cap
2.74B
Price-Earnings Ratio
25.72
Dividend Yield
Average Volume
1.89M
High Today
$23.75
Low Today
$23.31
Open Price
$23.43
Volume
153.27K
52 Week High
$24.22
52 Week Low
$9.70

Collections

CORT Earnings

$0.00
$0.11
$0.23
$0.34
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, After Hours

You May Also Like